DEVELOPING
76SERIOUSDOOM SCORE
Ebola outbreak expands in the Democratic Republic of the Congo as oral-drug trial begins
Democratic Republic of the Congo
PROCESSING CONFIDENCE98%Model confidence in the classification from supplied reports
COVERAGE2 reports2 publisher domains
FIRST DETECTEDSep 15, 2026, 2:31 PM UTCFirst time DoomRadar attached a report to this event
LAST MATERIAL CHANGENo later material changeRoutine duplicate coverage does not count as a material update
WHAT HAPPENED
The largest Ebola outbreak is expanding in the Democratic Republic of the Congo, with a reported 48% crude fatality rate. A clinical trial of oral drug NV-387 is scheduled to begin next week.
SO WHAT?
Continued expansion of a high-fatality Ebola outbreak creates a serious public-health risk and could increase transmission beyond affected areas.
SCORE CONTEXT
Why 76 is a serious score
7661–80
A score of 76 sits in DoomRadar's 61–80 band, which represents serious escalation or large-scale disruption. The score estimates potential severity and wider impact; it is not a probability or a forecast of losses.
See scoring methodology →EVIDENCE
How much reporting is behind this event
2REPORTS
2PUBLISHER DOMAINS
98%PROCESSING CONFIDENCE
Processing confidence reflects the model's confidence in its event classification from the supplied reports. It does not mean every claim in every linked report is independently verified.
LATEST REPORTING
Newest reports attached to this event
newjerseytelegraph.comSep 15, 2026, 3:17 PM UTCClinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in DR Congo with 48% Crude Fatality Rate, Says NanoViricidestennesseedaily.comSep 15, 2026, 2:31 PM UTCClinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in DR Congo with 48% Crude Fatality Rate, Says NanoViricides
FOR ME
Impact on Switzerland
Checking cached analysis...
MARKETS
Market impact
Checking cached analysis...
ALL SOURCES
Reports behind this event
newjerseytelegraph.comen
Clinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in DR Congo with 48% Crude Fatality Rate, Says NanoViricides
Sep 15, 2026, 3:17 PM UTC
tennesseedaily.comen
Clinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in DR Congo with 48% Crude Fatality Rate, Says NanoViricides
Sep 15, 2026, 2:31 PM UTC